Latest NewsOct 7, 2024HiFiBiO Therapeutics to Showcase DIS® Enabled Translational Insights from Ongoing Phase 1 Clinical Trials for Two Novel Immuno-Oncology Antibodies at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)All Filter By: Year2024202320222021202020192018201720162015Biotech2050 | Podcast | Jun 14, 2023HiFiBiO Therapeutics CEO Liang Schweizer Shares Her Professional Journey and the Company’s Pioneering DIS® Approach on the Biotech2050 PodcastApr 7, 2023HiFiBiO Therapeutics Announces Oral Presentation at 2023 American Association for Cancer Research (AACR) Annual MeetingMar 6, 2023Going Global: Insights on the Advantages of Biotech Globalization Published in Drug Discovery Today from HiFiBiO TherapeuticsJan 6, 2023HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603Life Science Success Podcast | Podcast | Jan 5, 2023HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by Life Science Success Podcast< 1 2 3 4 5 6 … 17 >
